Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Non-Current Assets (2014 - 2026)

Ocugen's (OCGN) quarterly Non-Current Assets came in at $18.4 million in Q1 2026, down 10.45% YoY from $20.5 million in Q1 2025, and down 4.29% on a QoQ basis from $19.2 million in Q4 2025.

Analysis

Ocugen (OCGN) Non-Current Assets (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Non-Current Assets data on file, last reported at $18.4 million in Q1 2026.

  • Quarterly Non-Current Assets fell 10.45% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.2 million (down 7.4% YoY) and the FY2025 annual result came in at $19.2 million, down 7.63% from the prior year.
  • Non-Current Assets retreated to $18.4 million in Q1 2026, from $19.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $21.9 million in Q2 2024 to a low of $3.7 million in Q1 2022.
  • A 5-year average of $16.6 million and a median of $19.2 million in 2025 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets soared 225.52% — and 2026, when it fell 10.45%.
  • Tracing OCGN's Non-Current Assets over 5 years: stood at $10.1 million in 2022, then surged by 112.78% to $21.6 million in 2023, then decreased by 3.78% to $20.8 million in 2024, then fell by 7.63% to $19.2 million in 2025, then retreated by 4.29% to $18.4 million in 2026.
  • The last three Non-Current Assets figures came in at $18.4 million (Q1 2026), $19.2 million (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 17.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.49 Mn
Mar 31, 2026 18.35 Mn
Dec 31, 2025 19.18 Mn
Sep 30, 2025 19.96 Mn
Jun 30, 2025 20.71 Mn
Mar 31, 2025 20.50 Mn
Dec 31, 2024 20.76 Mn
Sep 30, 2024 21.26 Mn
Jun 30, 2024 21.93 Mn
Mar 31, 2024 21.80 Mn
Dec 31, 2023 21.58 Mn
Sep 30, 2023 18.13 Mn
Jun 30, 2023 15.52 Mn
Mar 31, 2023 11.90 Mn
Dec 31, 2022 10.14 Mn
Sep 30, 2022 8.74 Mn
Jun 30, 2022 7.52 Mn
Mar 31, 2022 3.70 Mn
Dec 31, 2021 3.12 Mn
Sep 30, 2021 2.86 Mn